Login Register Cart 0
Generic placeholder image

Current Stem Cell Research & Therapy

Editor-in-Chief

ISSN (Print): 1574-888X
ISSN (Online): 2212-3946

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Stem Cells as a Therapeutic Choice in Dermatological Disorders

Author(s): Lili Legiawati*, Lis Surachmiati Suseno, Irma Bernadette S. Sitohang, Shannaz Nadia Yusharyahya, Athaya Ardelia and Kanya Paramastri

Volume 18, Issue 8, 2023

Published on: 27 October, 2022

Page: [1069 - 1075] Pages: 7

DOI: 10.2174/1574888X17666220930142513

Price: $65

Abstract

Stem cells are known for their extraordinary properties, mainly their potency, self-renewal, and clonality. In recent years, we have witnessed notable advancements in the field of cell therapy. Due to its remarkable properties and versatility, this cutting-edge therapy has now become a potentially promising cure for many diseases. Stem cell-based therapies have been utilized to treat various dermatological conditions, for instance, autoimmune skin disorders, atopic dermatitis, skin aging, wound healing, scar treatment, and many others. This article aims to serve as an overview of cell-based therapy's current application in dermatology field.

Keywords: dermatology, stem cell therapy, stem cells, alopecia, skin aging

« Previous Next »
Graphical Abstract

[1]
Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration 2013; 85(1): 3-10.
[http://dx.doi.org/10.1159/000345615] [PMID: 23257690]
[2]
Taub AF, Pham K. Stem cells in dermatology and anti-aging care of the skin. Facial Plast Surg Clin North Am 2018; 26(4): 425-37.
[http://dx.doi.org/10.1016/j.fsc.2018.06.004] [PMID: 30213424]
[3]
Nawab K, Bhere D, Bommarito A, Mufti M, Naeem A. Stem cell therapies: A way to promising cures. Cureus 2019; 11(9): e5712.
[http://dx.doi.org/10.7759/cureus.5712] [PMID: 31720180]
[4]
Mousaei GM, Seok J, Park HS, Liakath Ali FB, Al-Hendy A. Stem cell therapy: From idea to clinical practice. Int J Mol Sci 2022; 23(5): 2850.
[5]
Charitos IA, Ballini A, Cantore S, et al. Stem cells: A historical review about biological, religious, and ethical issues. Stem Cells Int 2021; 2021: 9978837.
[6]
Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: Past, present, and future. Stem Cell Res Ther 2019; 10(1): 68.
[http://dx.doi.org/10.1186/s13287-019-1165-5] [PMID: 30808416]
[7]
Urbán N, Cheung TH. Stem cell quiescence: The challenging path to activation. Development 2021; 148(3): dev165084.
[http://dx.doi.org/10.1242/dev.165084]
[8]
Preston SL, Alison MR, Forbes SJ, Direkze NC, Poulsom R, Wright NA. The new stem cell biology: Something for everyone. Mol Pathol 2003; 56(2): 86-96.
[http://dx.doi.org/10.1136/mp.56.2.86] [PMID: 12665626]
[9]
Prodinger CM, Reichelt J, Bauer JW, Laimer M. Current and future perspectives of stem cell therapy in dermatology. Ann Dermatol 2017; 29(6): 667-87.
[http://dx.doi.org/10.5021/ad.2017.29.6.667] [PMID: 29200755]
[10]
Biehl JK, Russell B. Introduction to stem cell therapy. J Cardiovasc Nurs 2009; 24(2): 98-103.
[http://dx.doi.org/10.1097/JCN.0b013e318197a6a5] [PMID: 19242274]
[11]
Ogliari KS, Marinowic D, Brum DE, Loth F. Stem cells in dermatology. An Bras Dermatol 2014; 89(2): 286-91.
[http://dx.doi.org/10.1590/abd1806-4841.20142530] [PMID: 24770506]
[12]
Khandpur S, Gupta S, Gunaabalaji DR. Stem cell therapy in dermatology. Indian J Dermatol Venereol Leprol 2021; 87(6): 753-67.
[http://dx.doi.org/10.25259/IJDVL_19_20] [PMID: 34245532]
[13]
Lee DK, Song SU. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications. Cell Immunol 2018; 326: 68-76.
[http://dx.doi.org/10.1016/j.cellimm.2017.08.009] [PMID: 28919171]
[14]
Shin TH, Lee BC, Choi SW, et al. Human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis via regulation of B lymphocyte maturation. Oncotarget 2017; 8(1): 512-22.
[http://dx.doi.org/10.18632/oncotarget.13473] [PMID: 27888809]
[15]
Orciani M, Campanati A, Caffarini M, et al. T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: At the origin of the problem. Br J Dermatol 2017; 176(6): 1569-76.
[http://dx.doi.org/10.1111/bjd.15078] [PMID: 27639070]
[16]
Kim HS, Yun JW, Shin TH, et al. Human umbilical cord blood mesenchymal stem cell-derived PGE2 and TGF-β1 alleviate atopic dermatitis by reducing mast cell degranulation. Stem Cells 2015; 33(4): 1254-66.
[http://dx.doi.org/10.1002/stem.1913] [PMID: 25522163]
[17]
Lee BC, Kim JJ, Lee JY, et al. Disease-specific primed human adult stem cells effectively ameliorate experimental atopic dermatitis in mice. Theranostics 2019; 9(12): 3608-21.
[http://dx.doi.org/10.7150/thno.32945] [PMID: 31281501]
[18]
Cho BS, Kim JO, Ha DH, Yi YW. Exosomes derived from human adipose tissue-derived mesenchymal stem cells alleviate atopic dermatitis. Stem Cell Res Ther 2018; 9(1): 187.
[http://dx.doi.org/10.1186/s13287-018-0939-5] [PMID: 29996938]
[19]
Kim HS, Lee JH, Roh KH, Jun HJ, Kang KS, Kim TY. Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: Phase I/IIa studies. Stem Cells 2017; 35(1): 248-55.
[http://dx.doi.org/10.1002/stem.2401] [PMID: 27256706]
[20]
Paganelli A, Tarentini E, Benassi L, Kaleci S, Magnoni C. Mesenchymal stem cells for the treatment of psoriasis: A comprehensive review. Clin Exp Dermatol 2020; 45(7): 824-30.
[http://dx.doi.org/10.1111/ced.14269] [PMID: 32386432]
[21]
Lim WS, Kim CH, Kim JY, Do BR, Kim EJ, Lee AY. Adipose-derived stem cells improve efficacy of melanocyte transplantation in animal skin. Biomol Ther 2014; 22(4): 328-33.
[http://dx.doi.org/10.4062/biomolther.2014.065] [PMID: 25143812]
[22]
Zhu L, Lin X, Zhi L, et al. Mesenchymal stem cells promote human melanocytes proliferation and resistance to apoptosis through PTEN pathway in vitiligo. Stem Cell Res Ther 2020; 11(1): 26.
[http://dx.doi.org/10.1186/s13287-019-1543-z] [PMID: 31941556]
[23]
Lee AY, Kim JY, Park CD, Lee JH, Lee CH, Do BR. Co-culture of melanocytes with adipose-derived stem cells as a potential substitute for co-culture with keratinocytes. Acta Derm Venereol 2012; 92(1): 16-23.
[http://dx.doi.org/10.2340/00015555-1174] [PMID: 21879248]
[24]
Matsuzaki K, Kumagai N. Treatment of vitiligo with autologous cultured keratinocytes in 27 cases. Eur J Plast Surg 2013; 36(10): 651-6.
[http://dx.doi.org/10.1007/s00238-013-0875-7] [PMID: 24039346]
[25]
Ramos MG, Ramos DG, Ramos CG. Evaluation of treatment response to autologous transplantation of noncultured melanocyte/keratinocyte cell suspension in patients with stable vitiligo. An Bras Dermatol 2017; 92(3): 312-8.
[http://dx.doi.org/10.1590/abd1806-4841.20175700] [PMID: 29186240]
[26]
Mulekar SV. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation. Arch Dermatol 2004; 140(10): 1211-5.
[http://dx.doi.org/10.1001/archderm.140.10.1211] [PMID: 15492183]
[27]
Toossi P, Shahidi DM, Mahmoudi RM, Fesharaki RJ. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: A clinical trial in an Iranian population. J Eur Acad Dermatol Venereol 2011; 25(10): 1182-6.
[http://dx.doi.org/10.1111/j.1468-3083.2010.03946.x] [PMID: 21214632]
[28]
Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100(9): 1249-60.
[http://dx.doi.org/10.1161/01.RES.0000265074.83288.09] [PMID: 17495232]
[29]
Owczarczyk SA, Wociór A, Placek W, Maksymowicz W, Wojtkiewicz J. The use of adipose-derived stem cells in selected skin diseases (vitiligo, alopecia, and nonhealing wounds). Stem Cells Int 2017; 2017: 4740709.
[http://dx.doi.org/10.1155/2017/4740709] [PMID: 28904532]
[30]
Shin H, Ryu HH, Kwon O, Park BS, Jo SJ. Clinical use of conditioned media of adipose tissue-derived stem cells in female pattern hair loss: A retrospective case series study. Int J Dermatol 2015; 54(6): 730-5.
[http://dx.doi.org/10.1111/ijd.12650] [PMID: 25777970]
[31]
Fukuoka H, Narita K, Suga H. Hair regeneration therapy: Application of adipose-derived stem cells. Curr Stem Cell Res Ther 2017; 12(7): 531-4.
[PMID: 28530535]
[32]
Narita K, Fukuoka H, Sekiyama T, Suga H, Harii K. Sequential scalp assessment in hair regeneration therapy using an adipose-derived stem cell-conditioned medium. Dermatol Surg 2020; 46(6): 819-25.
[http://dx.doi.org/10.1097/DSS.0000000000002128] [PMID: 31490301]
[33]
Fukuoka H, Suga H. Hair regeneration treatment using adipose-derived stem cell conditioned medium: Follow-up with trichograms. Eplasty 2015; 15: e10.
[PMID: 25834689]
[34]
Conget P, Rodriguez F, Kramer S, et al. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 2010; 12(3): 429-31.
[http://dx.doi.org/10.3109/14653241003587637] [PMID: 20230217]
[35]
El-Darouti M, Fawzy M, Amin I, et al. Treatment of dystrophic epidermolysis bullosa with bone marrow non-hematopoeitic stem cells: A randomized controlled trial. Dermatol Ther 2016; 29(2): 96-100.
[http://dx.doi.org/10.1111/dth.12305] [PMID: 26439431]
[36]
Wagner JE, Ishida YA, McGrath JA, et al. Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 2010; 363(7): 629-39.
[http://dx.doi.org/10.1056/NEJMoa0910501] [PMID: 20818854]
[37]
Petrof G, Lwin SM, Martinez QM, et al. Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 2015; 135(9): 2319-21.
[http://dx.doi.org/10.1038/jid.2015.158] [PMID: 25905587]
[38]
Yun IS, Jeon YR, Lee WJ, et al. Effect of human adipose derived stem cells on scar formation and remodeling in a pig model: A pilot study. Dermatol Surg 2012; 38(10): 1678-88.
[http://dx.doi.org/10.1111/j.1524-4725.2012.02495.x] [PMID: 22804839]
[39]
Zhang Q, Liu LN, Yong Q, Deng JC, Cao WG. Intralesional injection of adipose-derived stem cells reduces hypertrophic scarring in a rabbit ear model. Stem Cell Res Ther 2015; 6(1): 145.
[http://dx.doi.org/10.1186/s13287-015-0133-y] [PMID: 26282394]
[40]
Klinger M, Caviggioli F, Klinger FM, et al. Autologous fat graft in scar treatment. J Craniofac Surg 2013; 24(5): 1610-5.
[http://dx.doi.org/10.1097/SCS.0b013e3182a24548] [PMID: 24036737]
[41]
Gentile P, De Angelis B, Pasin M, et al. Adipose-derived stromal vascular fraction cells and platelet-rich plasma: Basic and clinical evaluation for cell-based therapies in patients with scars on the face. J Craniofac Surg 2014; 25(1): 267-72.
[http://dx.doi.org/10.1097/01.scs.0000436746.21031.ba] [PMID: 24406591]
[42]
Morimoto N, Ito T, Takemoto S, et al. An exploratory clinical study on the safety and efficacy of an autologous fibroblast-seeded artificial skin cultured with animal product-free medium in patients with diabetic foot ulcers. Int Wound J 2014; 11(2): 183-9.
[http://dx.doi.org/10.1111/j.1742-481X.2012.01064.x] [PMID: 22958543]
[43]
Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of dermagraft in improving the healing of chronic diabetic foot ulcers: Results of a prospective randomized trial. Diabetes Care 2003; 26(6): 1701-5.
[http://dx.doi.org/10.2337/diacare.26.6.1701] [PMID: 12766097]
[44]
Pajardi G, Rapisarda V, Somalvico F, et al. Skin substitutes based on allogenic fibroblasts or keratinocytes for chronic wounds not responding to conventional therapy: A retrospective observational study. Int Wound J 2016; 13(1): 44-52.
[http://dx.doi.org/10.1111/iwj.12223] [PMID: 24517418]
[45]
Kan T, Takahagi S, Matsubara D, et al. Clinical course of more than 10 years in a patient with extensive skin burns who received cultured epidermal autograft transplantation. Regen Ther 2022; 19(154): 154-7.
[http://dx.doi.org/10.1016/j.reth.2022.01.007]
[46]
Auxenfans C, Menet V, Catherine Z, et al. Cultured autologous keratinocytes in the treatment of large and deep burns: A retrospective study over 15 years. Burns 2015; 41(1): 71-9.
[http://dx.doi.org/10.1016/j.burns.2014.05.019] [PMID: 24996248]
[47]
Chua AWC, Khoo YC, Truong TTH, Woo E, Tan BK, Chong SJ. From skin allograft coverage to allograft-micrograft sandwich method: A retrospective review of severe burn patients who received conjunctive application of cultured epithelial autografts. Burns 2018; 44(5): 1302-7.
[http://dx.doi.org/10.1016/j.burns.2018.01.021] [PMID: 29475746]
[48]
Nicholas MN, Yeung J. Current status and future of skin substitutes for chronic wound healing. J Cutan Med Surg 2017; 21(1): 23-30.
[http://dx.doi.org/10.1177/1203475416664037] [PMID: 27530398]
[49]
Qin H, Zhu X, Zhang B, Zhou L, Wang W. Clinical evaluation of human umbilical cord mesenchymal stem cell transplantation after angioplasty for diabetic foot. Exp Clin Endocrinol Diabetes 2016; 124(8): 497-503.
[http://dx.doi.org/10.1055/s-0042-103684] [PMID: 27219884]
[50]
Lu D, Chen B, Liang Z, et al. Comparison of bone marrow mesenchymal stem cells with bone marrow-derived mononuclear cells for treatment of diabetic critical limb ischemia and foot ulcer: A double-blind, randomized, controlled trial. Diabetes Res Clin Pract 2011; 92(1): 26-36.
[http://dx.doi.org/10.1016/j.diabres.2010.12.010] [PMID: 21216483]
[51]
Dash NR, Dash SN, Routray P, Mohapatra S, Mohapatra PC. Targeting nonhealing ulcers of lower extremity in human through autologous bone marrow-derived mesenchymal stem cells. Rejuvenation Res 2009; 12(5): 359-66.
[http://dx.doi.org/10.1089/rej.2009.0872] [PMID: 19929258]
[52]
Li Y, Xia W, Van Der Merwe L, Dai W, Lin C. Efficacy of stem cell therapy for burn wounds: A systematic review and meta-analysis of preclinical studies. Stem Cell Res Ther 2020; 11(1): 322.
[http://dx.doi.org/10.1186/s13287-020-01839-9] [PMID: 32727568]
[53]
Guillaume JP, Daumas A, Magalon J, et al. State of the art. Autologous fat graft and adipose tissue-derived stromal vascular fraction injection for hand therapy in systemic sclerosis patients. Curr Res Transl Med 2016; 64(1): 35-42.
[http://dx.doi.org/10.1016/j.retram.2016.01.006] [PMID: 27140597]
[54]
Rozier P, Maria A, Goulabchand R, Jorgensen C, Guilpain P, Noël D. Mesenchymal stem cells in systemic sclerosis: Allogenic or autologous approaches for therapeutic use? Front Immunol 2018; 9: 2938.
[http://dx.doi.org/10.3389/fimmu.2018.02938] [PMID: 30619298]
[55]
Burt RK, Shah SJ, Dill K, et al. Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): An open-label, randomised phase 2 trial. Lancet 2011; 378(9790): 498-506.
[http://dx.doi.org/10.1016/S0140-6736(11)60982-3] [PMID: 21777972]
[56]
Van Laar JM, Farge D, Sont JK, et al. Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: A randomized clinical trial. JAMA 2014; 311(24): 2490-8.
[http://dx.doi.org/10.1001/jama.2014.6368] [PMID: 25058083]
[57]
Sullivan KM, Goldmuntz EA, Keyes EL, et al. Myeloablative autologous stem-cell transplantation for severe scleroderma. N Engl J Med 2018; 378(1): 35-47.
[http://dx.doi.org/10.1056/NEJMoa1703327] [PMID: 29298160]
[58]
Nash RA, McSweeney PA, Nelson JL, et al. Allogeneic marrow transplantation in patients with severe systemic sclerosis: Resolution of dermal fibrosis. Arthritis Rheum 2006; 54(6): 1982-6.
[http://dx.doi.org/10.1002/art.21908] [PMID: 16732546]
[59]
Loh Y, Oyama Y, Statkute L, et al. Non-myeloablative allogeneic hematopoietic stem cell transplantation for severe systemic sclerosis: Graft-versus-autoimmunity without graft-versus-host disease? Bone Marrow Transplant 2007; 39(7): 435-7.
[http://dx.doi.org/10.1038/sj.bmt.1705611] [PMID: 17310133]
[60]
Kowal BO, Fransen J, Avouac J, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 2017; 76(8): 1327-39.
[http://dx.doi.org/10.1136/annrheumdis-2016-209909] [PMID: 27941129]
[61]
Leyendecker A Jr, Pinheiro CCG, Amano MT, Bueno DF. The use of human mesenchymal stem cells as therapeutic agents for the in vivo treatment of immune-related diseases: A systematic review. Front Immunol 2018; 9: 2056.
[http://dx.doi.org/10.3389/fimmu.2018.02056] [PMID: 30254638]
[62]
Wang M, Cao C, Sun J, et al. Application of autologous hematopoietic stem cell transplantation for pemphigus. Int J Dermatol 2017; 56(3): 296-301.
[http://dx.doi.org/10.1111/ijd.13461] [PMID: 28093721]
[63]
Vanikar A, Trivedi H, Patel R, Kanodia K, Modi P, Shah V. Allogenic hematopoietic stem cell transplantation in pemphigus vulgaris: A single-center experience. Indian J Dermatol 2012; 57(1): 9-11.
[http://dx.doi.org/10.4103/0019-5154.92667] [PMID: 22470200]
[64]
Vanikar AV, Modi PR, Patel RD, et al. Hematopoietic stem cell transplantation in autoimmune diseases: The Ahmedabad experience. Transplant Proc 2007; 39(3): 703-8.
[http://dx.doi.org/10.1016/j.transproceed.2007.01.070] [PMID: 17445577]
[65]
Ng SA, Sullivan KM. Application of stem cell transplantation in autoimmune diseases. Curr Opin Hematol 2019; 26(6): 392-8.
[http://dx.doi.org/10.1097/MOH.0000000000000531] [PMID: 31490316]
[66]
Oyama Y, Parker ER, Brieva J, et al. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory pemphigus foliaceus. Bone Marrow Transplant 2004; 34(12): 1097-8.
[http://dx.doi.org/10.1038/sj.bmt.1704679] [PMID: 15489875]
[67]
Zarei F, Abbaszadeh A. Application of cell therapy for anti-aging facial skin. Curr Stem Cell Res Ther 2019; 14(3): 244-8.
[http://dx.doi.org/10.2174/1574888X13666181113113415] [PMID: 30421684]
[68]
Chen S, He Z, Xu J. Application of adipose-derived stem cells in photoaging: Basic science and literature review. Stem Cell Res Ther 2020; 11(1): 491.
[http://dx.doi.org/10.1186/s13287-020-01994-z] [PMID: 33225962]
[69]
Zhang S, Dong Z, Peng Z, Lu F. Anti-aging effect of adipose-derived stem cells in a mouse model of skin aging induced by D-galactose. PLoS One 2014; 9(5): e97573.
[http://dx.doi.org/10.1371/journal.pone.0097573]
[70]
Weiss RA, Weiss MA, Beasley KL, Munavalli G. Autologous cultured fibroblast injection for facial contour deformities: A prospective, placebo-controlled, Phase III clinical trial. Dermatol Surg 2007; 33(3): 263-8.
[http://dx.doi.org/10.1097/00042728-200703000-00001] [PMID: 17338681]
[71]
Watson D, Keller GS, Lacombe V, Fodor PB, Rawnsley J, Lask GP. Autologous fibroblasts for treatment of facial rhytids and dermal depressions. A pilot study. Arch Facial Plast Surg 1999; 1(3): 165-70.
[http://dx.doi.org/10.1001/archfaci.1.3.165] [PMID: 10937098]
[72]
Nilforoushzadeh MA, Siadat AH, Arianrad M, Moulavi F, Baradaran EH, Esfahani MH. Soft tissue augmentation by autologous cultured fibroblasts transplantation for treatment of wrinkles and scars: A case series of 20 patients. J Res Med Sci 2010; 15(3): 167-71.
[PMID: 21526076]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy